The study was carried out on cancer patients receiving chemotherapeutic
agents in the haematology clinic of a training
hospital between March 01, 2011 and July 29, 2011. Thirty out
of 45 patients agreeing to participate in the study formed the
control group and the remaining 15 formed the intervention
group. Informed consent was obtained from both the intervention
and control group. A questionnaire for sociodemographic
features was administered to patients. Treatment of patients
in the intervention group was begun after they had attended
D outpatient haematology clinic. Two tablets (2x 400 mg) of
ginger were administered to patients in the intervention group
in both the morning and the evening throughout the course of
treatment. All patients in the intervention and control groups
also continued using a .soditim bicarbonate mouth care solution
in line with hospital protocol. Presence of nausea and/or
vomiting was recorded by a nurse twice daily during chemotherapy
and was recorded on the nausea and/or vomiting
follow up form. For the control group all the questionnaires
were administered, the antiemetic treatment of 3mg of setron